Steriod Injection for Back Pain associated with Bone Loss in Postmenopausal Women

Woman with back pain - BSN

(Best Syndication News) - Researchers from Henry Ford Hospital found that postmenopausal women who received epidural steroid injections to ease back pain had six-times the loss of bone density than what is usual after six months. The study results were published in the December 1 edition of the journal Spine.

The study’s lead author, Shlomo Mandel, M.D., a Henry Ford orthopedic physician, said that physicians should be careful when prescribing epidural steroid injections for patients that are at risk for bone loss. He suggests that physicians should consider prescribing calcium and vitamin D supplements and exercise to the patient as part of treatment regimen.

The researchers wanted to see if the steroid injections used to treat lumbar stenosis, an abnormal narrowing of the spinal canal, would increase the risk for postmenopausal bone loss in women.

Math Anxiety causes Brain to feel Physical Pain

Doing math - BSN

(Best Syndication News) - A study from the University of Chicago found that anxiety experienced doing math can cause a person to feel physical pain. The researchers found that the brain areas that register a threat of bodily harm, and in some instances physical pain, are activated when people are stressed over math problems.

Sian Beilock, professor of psychology at the University of Chicago, said that the brain response of a person suffering from math anxiety is similar to someone feeling physical pain. Sian said that the pain could be similar to a burning sensation experienced on a stove.

Aubagio (teriflunomide) Multiple Sclerosis drug gains FDA approval

Prescription bottle - BSN

(Best Syndication News) - The US Food and Drug Administration (FDA) approved Aubagio (teriflunomide) to treat relapsing types of multiple sclerosis in adults. The treatment is a once-a-day tablet.

The clinical trial results showed around a 30 percent lower rate of relapse in multiple sclerosis patients taking Aubagio compared to a placebo. The side effects reported from Aubagio included diarrhea, abnormal liver test, nausea, and hair loss.

There will be a Boxed Warning that will notify the patient and the doctors about the possibility of liver problems, a risk of death, and a risk for birth defects. Because of liver problems, doctors are instructed to test the blood periodically and when starting Aubagio for liver function. The Boxed Warning also has been flagged for possibly causing fetal harm because of animal studies that demonstrated this problem. Women of childbearing age have to have a negative pregnancy test before starting Aubagio and they have to use a birth control during the treatment.

Aspirin and other NSAID Pain Relievers might reduce Skin Cancer

aspirin - BSN

(Best Syndication News) - A study from Denmark found that squamous cell carcinoma, and malignant melanoma might be reduced when a person takes aspirin, ibuprofen, or naproxen on a regular basis. The reduction was seen when patients filled at least two prescriptions for nonsteroidal anti-inflammatory drugs (NSAIDs). They had a 15 percent decreased risk for developing squamous cell carcinoma and a 13 percent decreased risk for developing malignant melanoma. The study results were published online in CANCER, which is a journal of the American Cancer Society.

Sigrún Alba Jóhannesdóttir, BSc, of Aarhus University Hospital in Denmark along with colleagues investigated medical records from northern Denmark from 1991 through 2009. They found 1,974 diagnoses of squamous cell carcinoma, 13,316 diagnoses of basal cell carcinoma, and 3,242 diagnoses of malignant melanoma. They also compared information from 178,655 individuals that did not have skin cancer and compared this against their prescriptions. They were looking for prescription of two or more refills of an NSAID.

Anxiety and Depression associated with Arthritis

credit: National Cancer Institute Daniel Sone (Photographer) - PD

(Best Syndication News) - One-third of US adults with arthritis who are over the age of 45 also suffer from anxiety or depression. Researchers from the Centers for Disease Control and Prevention (CDC) published their results on anxiety and depression with arthritis patients in today’s issue of Arthritis Care & Research; a journal published by Wiley-Blackwell, which is also the official journal of the American College of Rheumatology (ACR).

Anxiety was around twice as common than depression in those suffering from arthritis. Despite the higher occurrence of anxiety, doctors tend to treat the depression more often. The researchers found anxiety in 31 percent of the participants, while depression was measured in 18 percent of the participants. Additionally, 84 percent of the participants who had depression also had anxiety.

Syndicate content


Post to Facebook

Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation.
Use of this site means that you agree to our TERMS OF SERVICE

Advertise On This Site
Copyright © 2006-2015 By Best Syndication All Rights Reserved